|
PRDM2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.017400E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.059120E-03 |
| Normal-vs-Stage2 |
1.380340E-02 |
| Normal-vs-Stage3 |
1.36559999996955E-06 |
| Normal-vs-Stage4 |
1.81167999999676E-05 |
| Stage1-vs-Stage2 |
8.602800E-01 |
| Stage1-vs-Stage3 |
2.869600E-02 |
| Stage1-vs-Stage4 |
8.372000E-04 |
| Stage2-vs-Stage3 |
1.471850E-01 |
| Stage2-vs-Stage4 |
3.905900E-02 |
| Stage3-vs-Stage4 |
4.094600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.382210E-04 |
| Normal-vs-AfricanAmerican |
6.363300E-03 |
| Normal-vs-Asian |
4.747700E-02 |
| Caucasian-vs-AfricanAmerican |
4.165000E-01 |
| Caucasian-vs-Asian |
9.426200E-01 |
| AfricanAmerican-vs-Asian |
7.398000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.72410000000612E-05 |
| Normal-vs-Female |
1.861180E-01 |
| Male-vs-Female |
1.438220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.995800E-03 |
| Normal-vs-Extreme_Weight |
1.011120E-04 |
| Normal-vs-Obese |
5.7332000000021E-05 |
| Normal-vs-Extreme_Obese |
9.994000E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.393600E-01 |
| Normal_Weight-vs-Obese |
4.689200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.084400E-01 |
| Extreme_Weight-vs-Obese |
8.181600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.764000E-01 |
| Obese-vs-Extreme_Obese |
5.358600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.863700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.739590E-03 |
| Normal-vs-Age(61-80Yrs) |
3.989100E-04 |
| Normal-vs-Age(81-100Yrs) |
2.987000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.319000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.881800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.379200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.356200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.487800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.967780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.590200E-04 |
| Normal-VS-Type2 PRCC |
3.80610000183523E-08 |
| Normal-VS-KIRP CIMP |
3.64449999999961E-05 |
| Normal-VS-Unclassified PRCC |
7.571600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.21629999999085E-05 |
| Type1 PRCC-VS-KIRP CIMP |
8.463900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.261600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.478000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.724840E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.560930E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.48520000023511E-07 |
| Normal-vs-N1 |
1.55189999961891E-07 |
| Normal-vs-N2 |
5.282000E-03 |
| N0-vs-N1 |
4.815400E-01 |
| N0-vs-N2 |
3.365000E-01 |
| N1-vs-N2 |
3.765200E-01 |
|
|
